C

Cel-Sci Corp
D

CVM

0.59980
USD
-0.00
(-0.78%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
38,271,501
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABEO
    -0.09500
    (-1.60%)
    5.85500 USD
    A
    ARCT
    -2.310
    (-12.60%)
    16.020 USD
    B
    BLCM
    -0.01620
    (-4.09%)
    0.36000 USD
    C
    CTIC
    0.11000
    (2.54%)
    4.44000 USD
    I
    IMV
    0.01000
    (1.96%)
    0.51000 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    M
    MYOV
    0
    (0%)
    0.000000 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.63 USD
    V
    VTVT
    1.350
    (8.46%)
    17.310 USD
    المزيد
الأخبار

العنوان: Cel/Sci Corp

القطاع: Healthcare
الصناعة: Biotechnology
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.